2.50
Hdl Handle:
http://hdl.handle.net/10755/165475
Category:
Abstract
Type:
Presentation
Title:
Patients' Perceptions of Chemotherapy Side Effects Burden
Author(s):
Nirenberg, A.; Jakel, P.
Author Details:
A. Nirenberg, Columbia University, School of Nursing, New York, New York, USA; P. Jakel
Abstract:
This study was designed to increase understanding of patients' perception of the burden of chemotherapy side effects (SE). Purpose: The objective of this exploratory cross-sectional study is to evaluate patient’s perception compared to providers’ assessment of burden of chemotherapy induced side effects. Theoretical/Scientific Framework: Previous literature indicates that patients are affected by both disease and treatment. Methods: Thirty-five chemotherapy patients were recruited from 6 centers. Selection was based on presence of two grade III/IV SEs within prior 9 weeks: anemia, constipation, diarrhea, febrile neutropenia (FN), mucositis, vomiting. Patients identified and ranked their 3 most burdensome SEs, indicated extent to which SE interfered with home, work, school, social relationships (lower scores indicate more interference; 1- 6). Patients were female (57%), white(80%),mean age 52. Primary sites were breast and lung. Data Analysis: Data analysis is exploratory in nature. Findings and Implications: Forty percent of patients had anemia. Fatigue was ranked most burdensome SE by 40% of patients and was listed in the top 3 most burdensome SE for 66%. Nausea or vomiting were mentioned as burdensome SEs by 40% of patients. A range of upper and lower GI symptoms were mentioned, with constipation, diarrhea, and/or irregular bowel movements ranked as top 3 burdensome SE (51%). Burdensome SEs included mouth sores, pain, SOB, appetite loss, and low blood cell counts. The most burdensome SE produced a mean score of 3.4 for interference at home, 3.6 for work, 3.2 for school, 3.8 for social activities. Concordance between selection criteria SEs and patient-rated burdensome SEs was moderate: 15 (43%) of the patients had constipation, only 1 patient rated this as the most burdensome symptom and only 7 (20%) mentioned constipation in the top 3. Mucositis was reported in 17 (49%) of patients and was rated as most burdensome by 11%. Eight (23%) patients had FN and low blood count was listed by 2 patients as one of the most burdensome SEs. Results suggest that NCI toxicity criteria do not correlate with patients' perceptions of SEs.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2004
Conference Name:
29th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Anaheim, California, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titlePatients' Perceptions of Chemotherapy Side Effects Burdenen_GB
dc.contributor.authorNirenberg, A.en_US
dc.contributor.authorJakel, P.en_US
dc.author.detailsA. Nirenberg, Columbia University, School of Nursing, New York, New York, USA; P. Jakelen_US
dc.identifier.urihttp://hdl.handle.net/10755/165475-
dc.description.abstractThis study was designed to increase understanding of patients' perception of the burden of chemotherapy side effects (SE). Purpose: The objective of this exploratory cross-sectional study is to evaluate patient’s perception compared to providers’ assessment of burden of chemotherapy induced side effects. Theoretical/Scientific Framework: Previous literature indicates that patients are affected by both disease and treatment. Methods: Thirty-five chemotherapy patients were recruited from 6 centers. Selection was based on presence of two grade III/IV SEs within prior 9 weeks: anemia, constipation, diarrhea, febrile neutropenia (FN), mucositis, vomiting. Patients identified and ranked their 3 most burdensome SEs, indicated extent to which SE interfered with home, work, school, social relationships (lower scores indicate more interference; 1- 6). Patients were female (57%), white(80%),mean age 52. Primary sites were breast and lung. Data Analysis: Data analysis is exploratory in nature. Findings and Implications: Forty percent of patients had anemia. Fatigue was ranked most burdensome SE by 40% of patients and was listed in the top 3 most burdensome SE for 66%. Nausea or vomiting were mentioned as burdensome SEs by 40% of patients. A range of upper and lower GI symptoms were mentioned, with constipation, diarrhea, and/or irregular bowel movements ranked as top 3 burdensome SE (51%). Burdensome SEs included mouth sores, pain, SOB, appetite loss, and low blood cell counts. The most burdensome SE produced a mean score of 3.4 for interference at home, 3.6 for work, 3.2 for school, 3.8 for social activities. Concordance between selection criteria SEs and patient-rated burdensome SEs was moderate: 15 (43%) of the patients had constipation, only 1 patient rated this as the most burdensome symptom and only 7 (20%) mentioned constipation in the top 3. Mucositis was reported in 17 (49%) of patients and was rated as most burdensome by 11%. Eight (23%) patients had FN and low blood count was listed by 2 patients as one of the most burdensome SEs. Results suggest that NCI toxicity criteria do not correlate with patients' perceptions of SEs.en_GB
dc.date.available2011-10-27T12:19:13Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:19:13Z-
dc.conference.date2004en_US
dc.conference.name29th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationAnaheim, California, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.